D3 5000 IU with Vitamin K2 Apricot Flavor
80/100
This product is generally safe
- Vitamin D3: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Vitamin D3: 0.125mg is 1.2× the Tolerable Upper Intake Level (0.1mg)
Label Data
1 Chewable Tablet(s)
Serving Size
90
Servings
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
125 mcg
(625% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.2× (UL: 0.1 mg)
📚 604 studies (Tier A: 16, B: 251)
90 mcg
(75% DV)
✅ Within RDA (0.8× RDA of 0.12 mg)
📚 273 studies (Tier A: 9, B: 175)
Other Ingredients
Xylitol
Sorbitol
Magnesium Stearate
Microcrystalline Cellulose
Dicalcium Phosphate
Silicon Dioxide
Natural Peach Flavor
natural Apricot flavor
Label Claims — Verification
❓
Nutrient
❓
All Other
All Other (100% of products)
Structure/Function (84% of products)
Nutrient (73% of products)
Target Groups
Vegetarian
Adult (18 - 50 Years)
Kosher
Women (not pregnant or lactating)
Product Information
📋 Directions for Use
Directions: As a dietary supplement, chew one (1) tablet daily. Dosage may be increased as directed by a healthcare practitioner.
⚠️ Warnings & Precautions
Double-sealed for your protection. Do not use if outer seal is broken or missing.
Caution: Keep out of reach of children.
Not to be taken by pregnant or lactating women
Made in a GMP facility that processes egg, fish, milk, peanut, sesame, shellfish, soy, tree nut and wheat products.
🧪 Formulation Notes
Certified Kosher.
Made in the U.S.A.
No added sugar
Additional Information
Shield Star K (Kosher) Parve
Family owned and operated
Product Details
UPC / SKU
7 55929 10403 1
DSLD Entry Date
2023-12-14
Product Type
Vitamin
Form
Tablet or Pill
DSLD ID
303376
Data Updated
2026-04-11
Research Evidence
332
Research Sources
59
Avg Quality Score
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
A
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Compare Similar Products
Vitamin K 100 mcg
Vitamin World
100
Vitamin K2
Higher Nature
100
Vitamin K-1
The Vitamin Shoppe
100
Vitamin K1 100 mcg
The Vitamin Shoppe
100
Vitamin K1 100 mcg
Country Life
100